Jeremy Shinoda, BA, BS, MBA - Cordant Health Solutions - Quality Compliance Analyst

Jeremy Shinoda

BA, BS, MBA

Cordant Health Solutions

Quality Compliance Analyst

United States

ORCID logohttps://orcid.org/0000-0003-2724-3240

Jeremy Shinoda, BA, BS, MBA - Cordant Health Solutions - Quality Compliance Analyst

Jeremy Shinoda

BA, BS, MBA

Introduction

Primary Affiliation: Cordant Health Solutions - United States

Education

Purdue University
Master of Business Administration
University of California San Diego
B.S. Biochemistry
University of California San Diego
B.A. Spanish Literature

Publications

6Publications

10Reads

85Profile Views

44PubMed Central Citations

Adenovirus-mediated gene therapy using human p21WAF-1/Cip-1 to prevent wound healing in a rabbit model of glaucoma filtration surgery.

Arch Ophthalmol 2002 Jul;120(7):941-9

Department of Ophthalmology and Visual Sciences, University of Wisconsin, Madison, 1300 University Ave, Room 6640 MSC, Madison, WI 53706-1532, USA.

View Article

Download full-text PDF

Source
July 2002
1 Read
8 Citations
4.400 Impact Factor

Adenoviral delivery of human and viral IL-10 in murine sepsis.

J Immunol 2001 Jul;167(2):1053-9

Department of Surgery, University of Florida College of Medicine, Gainesville, FL 32610, USA.

View Article

Download full-text PDF

Source
July 2001
10 Citations
4.922 Impact Factor

Specific depletion of human anti-adenovirus antibodies facilitates transduction in an in vivo model for systemic gene therapy.

Mol Ther 2001 May;3(5 Pt 1):768-78

Department of Molecular Biology, Canji, Inc., 3525 John Hopkins Court, San Diego, CA 92121, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1006/mthe.2001.0316DOI Listing
May 2001
7 Citations
6.230 Impact Factor